Associations between macrophage inhibitor factor, anxiety and depression in patients with ST-segment elevation myocardial infarction
Article Sidebar
Main Article Content
Abstract
The aim – to investigate associations between macrophage inhibitory factor (MIF) and anxiety, depression and stress in patients with ST-segment elevation myocardial infarction (STEMI).
Materials and methods. 73 patients with STEMI with TIMI-III aged 58.37±10.34 were enrolled in the study. Revascularization tactics distribution was the following: 43 (58.9 %) patients underwent primary percutaneous coronary intervention using bare-metal coronary stent, 30 (41.1 %) – pre-hospital thrombolysis with subsequent percutaneous coronary intervention within12 hours. Echocardiography was done during the period of hospitalization. Serum MIF was studied using the enzyme linked immunoassay method. Anxiety, depression and stress were determined with DASS-21 questionnaire.
Results and discussion. When comparing the median values of the MIF level in STEMI patients, a statistically significant increase in the MIF concentration relative to control group (2582.80 [1308.40–4122.20] and 573.75 [397.80–1016.75] ng/ml, p<0.001). It evidences the activation of the formation of MIF after the index event. Positive correlation was determined between the level of MIF, the level of troponin I (r=0.33; р=0.045) and blood leukocytes (r=0.36; р=0.039) that confirms its involvement into inflammation and necrosis processes. The univariant and multivariate analysis revealed the effect of the degree of depression and anxiety growth on the DASS-21 questionnaire (p=0.0138 and p=0.0050, respectively) on the increasing of the MIF.
Conclusions. The data obtained confirm the relationship between the MIF and anxiety and depression prior the onset of myocardial infarction, indicating their influence on the processes of inflammation.
Article Details
Keywords:
References
Asare Y, Schmitt M, Bernhagen J. The vascular biology of macrophage migration inhibitory factor (MIF) Expression and effects in inflammation, atherogenesis and angiogenesis. Thromb Haemost. 2013;109(03):391–398
Bay-Richter C, Janelidze S, Sauro A, Bucala R, Lipton J. Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice. J Neuroinflammation. 2015 Sep 4;12:163. http://doi.org/10.1186/s12974-015-0387-4.
Berezin AE. Endogenous vascular repair system in cardiovascular disease: The role of endothelial progenitor cells. AMJ 2019;12(2):42–48. https://doi.org/10.21767/AMJ.2018.3464.
Bloom J., Al-Abed Y. MIF: Mood Improving/Inhibiting Factor? Journal of Neuroinflammation. BioMed Central Ltd. 2014. https://doi.org/10.1186/1742-2094-11-11
Chan W, White DA, Wang X-Y, Bai R-F, Liu Y, Yu H-Y, Zhang Y-Y, Fan F, Schneider HG, Duffy SJ, Taylor AJ, Du X-J, Gao W, Gao X-M, Dart AM, Macrophage migration inhibitory factor for the early prediction of infarct size. J Am Heart Assoc. 2013;2(5):e000226. http://doi.org/10.1161/JAHA.113.000226
Chen L, Yang G, Zhang X, Wu J, Gu Q, Wei M, Yang J, Zhu Y, Wang N, Guan Y.Induction of MIF expression by oxidized LDL via activation of NF-kB in vascular smooth muscle cells. Atherosclerosis. 2009;207(2):428–423. http://doi.org/10.1016/j.atherosclerosis.2009.05.021
Conboy L, Varea E, Castro JE, Sakouhi-Ouertatani H, Calandra T, Lashuel HA, Sandi C. Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors. Mol Psychiatry. 2011 May;16(5):533–47. http://doi.org/10.1038/mp.2010.15. Epub 2010 Feb 23 http://doi.org/10.1038/mp.2010.15
Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med. 2002 Nov;8(11):1249–56. http://doi.org/10.1038/nm1102-1249
Edwards KM, Bosch JA, Engeland CG, Cacioppo JT, Marucha PT. Elevated macrophage migration inhibitory factor (MIF) is associated with depressive symptoms, blunted cortisol reactivity to acute stress, and lowered morning cortisol. Brain Behav Immun. 2010 Oct;24(7):1202–8. http://doi.org/10.1016/j.bbi.2010.03.011. Epub 2010 Apr 9.
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177
Itabe H. Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis. J.Clin.Biochem.Nutr. 2012;51(1):1–8. http://doi.org/10.3164/jcbn.11-00020R1
Kong YZ, Yu X, Tang JJ, Ouyang X, Huang XR, Fingerle-Rowson G, Bacher M, Scher LA, Bucala R, Lan HY. Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques. Atherosclerosis. 2005 Jan;178(1):207–15. http://doi.org/10.1016/j.atherosclerosis.2004.08.030
Lampropoulos K, Kavvouras C, Megalou A, Tsikouri P, Kafkala C, Derka D, Bonou M, Barbetseas J. Association between anxiety and depression in patients with acute coronary syndromes due to financial crisis. Kardiologia Polska. 2016; 74(10):1154-1159. http://doi.org/10.5603/KP.a2016.0059
Lu XT, Liu YF, Zhao L, Li WJ, Yang RX, Yan FF, Zhao YX, Jiang F. Chronic psychological stress induces vascular inflammation in rabbits. Stress. 2013 Jan;16(1):87-98. http://doi.org/10.3109/10253890.2012.676696. Epub 2012 Apr 25.
Müller II, Müller KA, Schönleber H, Karathanos A, Schneider M, Jorbenadze R, Bigalke B, Gawaz M, Geisler T. Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response. PLoS One 2012;76: http://doi.org/10.1371/journal.pone.0038376.
Sedding DG, Boyle EC, Demandt JAF, Sluimer JC, Dutzmann J, Haverich A, Bauersachs J. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease. Front. Immunol. 2018;9:706. http://doi.org/10.3389/fimmu.2018.00706
Xu T, Pu S, Ni Y, Gao M, Gao M, Li X, Zeng X Elevated plasma macrophage migration inhibitor factor as a risk factor for the development of post-stroke depression in ischemic stroke. J Neuroimmunol. 2018 Jul 15;320:58–63. http://doi.org/10.1016/j.jneuroim.2018.04.003. Epub 2018 Apr 10.
White DA, Fang L, Chan W, Morand EF, Kiriazis H, Duffy SJ, Taylor AJ, Dart AM, Du X-J, Gao X-M Pro-Inflammatory Action of MIF in Acute Myocardial Infarction via Activation of Peripheral Blood Mononuclear Cells. PLoS ONE 2013;8(10). http://doi.org/10.1371/journal.pone.0076206.
Yüksel A, Bilgir F, Bilgir O, Calan M, Bozkaya IG. Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease Clinics (Sao Paulo). 2015 Mar;70(3):169–72. http://doi.org/10.6061/clinics/2015(03)03. Epub 2015 Mar 1